Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction | Cell Death & Disease
Current hypotheses for the involvement of a-synuclein in Parkinson's... | Download Scientific Diagram
![PDF] Oxidative Stress, a-Synuclein, and Apoptosis in Parkinson's Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e6896be20353311c87e66a5c46d0c1255dce0ad0/5-Figure2-1.png "PDF] Oxidative Stress, a-Synuclein, and Apoptosis in Parkinson's Disease | Semantic Scholar")
PDF] Oxidative Stress, a-Synuclein, and Apoptosis in Parkinson's Disease | Semantic Scholar
Alpha-Synuclein aggregation HTRF kit | Cisbio
Alpha-synuclein - Wikipedia
IJMS | Free Full-Text | The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Life | Free Full-Text | Keeping α-Synuclein at Bay: A More Active Role of Molecular Chaperones in Preventing Mitochondrial Interactions and Transition to Pathological States?
Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology - Tyson - 2016 - Journal of Neurochemistry - Wiley Online Library
Zeroing in on neurodegenerative α-synuclein | Nature Reviews Drug Discovery
Targeting alpha-synuclein in the gut may slow | EurekAlert!
Alpha-synuclein - Wikipedia
Snaring the Function of α-Synuclein: Cell
IJMS | Free Full-Text | The Role of α-Synuclein Oligomers in Parkinson's Disease
Human recombinant a-Synuclein (1-140), HiLyte™ Fluor 488 labeled - 200 µg
Conformation-specific Antibodies Targeting Aggregated Forms of α-synuclein Block the Propagation of Synucleinopathy
Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy | Science Advances
Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis - ScienceDirect
Pathological roles of α-synuclein in neurological disorders - The Lancet Neurology
α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration: Cell Reports
Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease | Pharmacological Reviews
Modulating membrane binding of α-synuclein as a therapeutic strategy | PNAS
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3 | Science
Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration | Acta Neuropathologica Communications | Full Text
α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis - ScienceDirect
